# Evaluation of Anterior Repositioning Guided Splint Combined With or Without I Platelet-rich Fibrin

> **NCT06132802** · NA · COMPLETED · sponsor: **Mahmoud Mohammed Mahmoud Nasef** · enrollment: 30 (actual)

## Conditions studied

- Temporomandibular Joint Disorders

## Interventions

- **PROCEDURE:** Patients who received treatment involving ARS and arthrocentesis only
- **PROCEDURE:** Patients who received treatment involving ARS, arthrocentesis, and an I-PRF injection

## Key facts

- **NCT ID:** NCT06132802
- **Lead sponsor:** Mahmoud Mohammed Mahmoud Nasef
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-02
- **Primary completion:** 2022-10-14
- **Final completion:** 2022-10-14
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2023-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06132802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06132802, "Evaluation of Anterior Repositioning Guided Splint Combined With or Without I Platelet-rich Fibrin". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06132802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*